ASBrS 2020 Industry Symposia

Exact Sciences Corporation (formerly Genomic Health, Inc.)

Less is More: De-escalation of Local and Systemic Therapy with the Breast Recurrence Score® Test

Presenters:

• Julia White, MD, Ohio State University Comprehensive Cancer Center
• Anthony Lucci, MD, University of Texas, MD Anderson Cancer Center

How to Register:

Please visit Exact Sciences Symposium.

---

Note: This satellite symposium is supported by Exact Sciences Corporation (formerly Genomic Health, Inc.) through a marketing grant. It is not part of the official program of the ASBrS. This activity is free to all registered attendees.

Albert Einstein College of Medicine-Montefiore Medical Center

Enhanced Recovery in Breast Reconstruction: Discussion of Analgesic Strategies

Room: DaVinci 3&4

Speakers:

• Shawna Willey, MD, Inova Schar Cancer Institute, Fairfax, VA
• Jeffrey C. Gadsden, MD, FRCPC, FANZCA, Duke University School of Medicine, Durham, NC

How to Register:

www.eeds.com/live/789066

For More Information:

Contact Stacy Atkinson, MS, CMP, CHCP at 718‑920‑6674, or statkins@montefiore.org.

This activity is accredited by Albert Einstein College of Medicine-Montefiore Medical Center for 1.25 AMA PRA Category 1 Credits™.

Description:

Optimization of pain control while minimizing side-effects from medications is one of the core elements of enhanced recovery for breast cancer surgery. Targeted local infiltration techniques and ultrasound-guided chest wall blocks are becoming increasingly popular and have been shown to provide enhanced analgesia for breast procedures. With their favorable risk and side effect profile, these techniques are rapidly becoming a standard in many centers.

At this interactive panel discussion, participants will learn about optimizing analgesia during breast procedures from both the surgical oncologist and anesthesiologist perspectives. Participants will learn the indications, benefits, technical tips and evidence supporting the performance of these analgesic techniques.

Objectives:

• Explain the rationale for optimizing pain control patients undergoing surgery for breast cancer, and the impact of uncontrolled postoperative pain
• Define the goals of multimodal analgesia and the relative value of techniques that employ local anesthetics
• Discuss the benefits of opioid-sparing treatment regimens in the care of patients experiencing post-surgical pain
• Apply best practices pertaining to the administration of local anesthetics during breast cancer surgery by both the surgeon and anesthesiologist

---

Note: This satellite symposium is supported by Pacira Pharmaceuticals through an educational grant provided to Albert Einstein College of Medicine-Montefiore Medical Center. CME credits for this program will be provided by Albert Einstein College of Medicine-Montefiore Medical Center. It is not part of the official program of the ASBrS*. This activity is free to all registered attendees. (*An independent grant from Albert Einstein College of Medicine-Montefiore Medical Center was provided to the ASBrS in order to offer this satellite symposium during the 21st Annual Meeting.)

PeerView Institute

The Era of Immuno-Oncology in TNBC: Navigating Evidence in Early-Stage & Advanced Disease, Practicalities of Integration, and Implications for Breast Surgeons

Program Objective:

After participating in the activity, the learners are expected to be better able to:

1. Describe the foundational aspects of and rationale for harnessing the immune system in the treatment of triple-negative breast cancer (TNBC)
2. Discuss efficacy, safety, biomarker, and other key data from clinical trials assessing immune checkpoint inhibitors and immunotherapy-based combinations in advanced and early-stage TNBC
3. Integrate immunotherapies into multimodal management of patients with advanced and early-stage TNBC according to the latest evidence and best practice recommendations, and in the context of effective multidisciplinary collaboration and coordination of care

Brief Summary of Program:

This educational program will provide participating breast surgeons, breast oncologists, and other professionals involved in the care with patients with breast cancer with up-to-date information on the current and emerging role of cancer immunotherapies in triple-negative breast cancer (TNBC). Experts will evaluate the accumulating evidence from clinical trials and highlight the evolving role of immune checkpoint inhibition in metastatic and early-stage disease settings of TNBC. Practical guidance will also be provided related to the nuances of integration of immunotherapies and combinations into treatment plans for patients with TNBC throughout the disease continuum, and how to maximize the potential of these agents in the context of multimodal therapy and multidisciplinary patient care.

How to Register:

To register, please visit PeerView.com/TNBCLV20. For additional information about the program, contact PeerView at 1.877.833.6141 or live@PeerView.com.

This CME activity is jointly provided by Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education. This activity is supported by an independent educational grant from Merck & Co., Inc.

---

Note: This satellite symposium is supported by Merck & Co., Inc., through an independent educational grant provided by Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education. CME credits for this program will be provided by Medical Learning Institute, Inc. It is not part of the official program of the ASBrS. This activity is free to all registered attendees.

Agendia, Inc.

Comprehensive Profiling of Early-Stage Breast Cancer: A More Effective Path to Treatment Planning

Program Objective:

To educate the audience on ways genomic profiling may facilitate a faster, clearer and more effective path to care for women with early stage breast cancer.

Brief Summary of Program:

Physicians face many challenges when trying to formulate both pre- and post-operative treatment plans. This session will explore time to treatment and how the implementation of comprehensive decision support tools can reliably support medical management decisions to improve patient outcomes.

How to Register:

For additional information about the program and how to register, please contact Dina Scaglione at dina.scaglione@agendia.com.

---

Note: This satellite symposium is supported by Agendia through a marketing grant. It is not part of the official program of the ASBrS. This activity is free to all registered attendees.

Myriad Genetic Laboratories, Inc.

riskScore: Using the next generation of risk models for more precise and personalized cancer risk

Program Objective:

• Describe how riskScore analyzes over 80 well-studied genetic markers and combined with the Tyrer-Cuzick model estimates a woman’s risk for developing breast cancer
• Learn how the model was validated and can be utilized in clinic today
• Summarize how the utilization of polygenic risk scores significantly modifies the risk of patients who carry a mutation in BRCA1, BRCA2, ATM, CHEK2, or PALB2

Brief Summary of Program:

In this course, we will discuss how riskScore is a precision medicine tool clinically validated to predict a woman’s risk of developing breast cancer. We will illustrate on how it analyzes family history, personal clinical risk factors, and over 80 well-studied genetic markers to predict the risk of developing breast cancer over the next 5 years and remaining lifetime. In addition, we will cover possible advances such as expanding its availability to all ancestries and leveraging it to refine the risk for mutation carriers.

How to Register:

myriadriskscore.rsvpify.com

---

Note: This satellite symposium is supported by Myriad Genetic Laboratories, Inc., through a marketing grant. It is not part of the official program of the ASBrS. This activity is free to all registered attendees.

Stryker

The Hidden Scar Program: Tools and techniques that differentiate your breast practice and patient survivorship

Program Objective:

• Overview of Hidden Scar technique and program
• Learn how to leverage the Hidden Scar Program in your practice to increase patient volumes and expand surgical options
• Hear from surgeons and patients to understand the impact of Hidden Scar on survivorship and how to discuss this surgical approach
• Find out how you can become a Hidden Scar certified surgeon

Description of Program:

This symposium will discuss the Hidden Scar Program and explore the impact on both your patients and practice. Keynote speakers will explain tools that differentiate your breast program, and surgeons and patients will share their experience with Hidden Scar and survivorship. Explore interactive Hidden Scar activations to learn how you can become Hidden Scar certified, the impact of this program on Hidden Scar patients, and about upcoming educational opportunities in your community.

How to Register:

For additional information about the program and how to register, please contact Kimmy Sullivan at kimmy.sullivan@stryker.com.

---

Note: This satellite symposium is supported by Stryker through a marketing grant. It is not part of the official program of the ASBrS. This activity is free to all registered attendees.

Hologic

A case-based approach to optimal surgical treatment of breast reconstruction, localization and radiation planning: A panel discussion on advancing the standard of care and improving outcomes

Description:

An interactive panel discussion designed to highlight optimal breast reconstruction, localization techniques, radiation planning along with specimen radiography through examination of actual cases and outcomes. Participants will have an opportunity to ask questions, share perspectives and hear about the latest breast reconstruction methods from a multi-disciplinary team including surgery, radiology, and radiation oncology practicing in both academic and community based centers.

Speakers:

• Karen Barbosa, MD
• Anthony Lucci, MD
• Joshua Mondschein, MD

For More Information:

For more information about the breakfast symposium, contact MedEd-BSH@hologic.com. For additional education opportunities, visit HologicED.com.

---

Note: This satellite symposium is supported by Hologic, Inc., through a marketing grant. It is not part of the official program of the ASBrS. This activity is free to all registered attendees.

Medtronic

"Updates in Nipple Sparing Mastectomy"

Program Objective

• Discuss Advances in Nipple Sparing Mastectomies
• Describe how to effectively address individual patient needs
• Evaluate individual surgeon needs
• Review the benefits of teamwork and collaboration

Brief Summary of Program

Join us for a discussion highlighting contemporary advances in Nipple Sparing Mastectomies and Reconstructive Techniques. Information will be shared with the audience to effectively address individual patient and surgeon needs, with special emphasis on the crucial role of teamwork.

How to Register:

Please click the following link: medtronic.cvent.com/ASBrSbreakfast

---

Note: This satellite symposium is supported by Medtronic, through a marketing grant. It is not part of the official program of the ASBrS. This activity is free to all registered attendees.